Fucidin is an antibacterial medicine most commonly used in cream or ointment form to treat superficial skin infections caused by susceptible bacteria, especially Staphylococcus aureus. Typical indications include impetigo, infected cuts and abrasions, folliculitis, infected eczema or dermatitis, and small post-procedural wounds at risk of staph contamination. In these situations, the topical antibiotic helps reduce bacterial load, limits spread to surrounding skin, and supports faster symptom relief when combined with gentle cleansing and proper wound care.
An ophthalmic formulation (fusidic acid eye drops/gel) may be prescribed for bacterial conjunctivitis due to susceptible organisms. Less commonly, systemic (oral) fusidic acid is used under specialist guidance for serious staphylococcal infections, often in combination with another antibiotic to prevent resistance. Because antibiotics should only be used when clearly indicated, proper diagnosis is important to distinguish bacterial infections from viral, fungal, or noninfectious dermatoses that require different treatment.
Topical skin use (cream or ointment): After washing hands and gently cleaning the affected area with mild soap and water, apply a thin layer of Fucidin to the infected skin two to three times daily, or as directed by your clinician. A small amount is usually sufficient to cover the lesion; avoid smearing over large areas of healthy skin. Treatment courses typically last 7 to 10 days. If your provider has advised it, you may cover the area with a light, breathable dressing; avoid tight occlusive coverings unless specifically instructed.
Ophthalmic use (eye drops/gel): For bacterial conjunctivitis, many labels recommend one drop in the affected eye(s) twice daily for 7 days, or as directed. Wash hands before and after administration, avoid touching the dropper tip to the eye or any surface, and remove contact lenses before use. Vision may blur briefly after application; do not drive until clear.
Systemic use (oral fusidic acid/sodium fusidate): Dosing is individualized by a clinician, commonly given two to three times daily and often combined with another agent. Because systemic fusidic acid carries important drug interaction and liver considerations, do not self-dose. Children require weight-based dosing. If infection does not improve within a few days of appropriate use or worsens, seek clinical review to reassess diagnosis, adherence, and the need for culture or alternative therapy.
Do not use Fucidin if you have a known allergy to fusidic acid or any cream/ointment excipients (for example, lanolin, cetyl alcohol, or butylhydroxytoluene in certain brands). Avoid applying to large areas, chronic leg ulcers, or deep, open wounds unless advised by a clinician. Fucidin is ineffective against fungi, viruses, or parasites; using it in these conditions can delay correct care and promote resistance. For facial use, keep away from eyes and mucous membranes; use the ophthalmic formulation if the eye is involved.
In pregnancy and breastfeeding, short courses of topical Fucidin are generally considered low risk when used on small areas of intact skin; still, consult a healthcare professional, especially if treating the breast area or large surfaces. People with liver disease should avoid systemic fusidic acid unless closely supervised. Antibiotic stewardship matters: use the shortest effective course, do not share medications, and do not save partially used tubes for unrelated rashes.
Fucidin is contraindicated in individuals with hypersensitivity to fusidic acid or formulation ingredients. Ophthalmic preparations are contraindicated for wearers of contact lenses during active infection; remove lenses prior to dosing and wait for clinician clearance before reinsertion. Systemic fusidic acid may be inappropriate in those with a history of cholestatic jaundice linked to fusidic acid, and it must not be combined with certain statins due to severe interaction risk. Always review ingredients and your medical history with a clinician before starting therapy.
Most people tolerate topical Fucidin well. The most common reactions are mild and localized: transient stinging or burning at the application site, itching, dryness, erythema, or irritation. Contact dermatitis can occur, sometimes due to the active ingredient, sometimes from excipients in the base. If irritation is marked or worsening, stop use and seek advice to rule out allergy or a misdiagnosed condition.
With ophthalmic Fucidin, brief stinging, blurred vision, or watery discharge may occur after instillation. Avoid driving until vision clears. Any severe eye pain, marked swelling, or change in vision warrants urgent care.
Systemic fusidic acid can cause gastrointestinal upset (nausea, abdominal pain, diarrhea) and, rarely, liver-related side effects including cholestatic jaundice. Severe, persistent diarrhea may signal antibiotic-associated colitis and needs prompt evaluation. Signs of an allergic reaction include rash, hives, swelling of the face or throat, breathing difficulty, or dizziness; these require immediate medical attention.
Topical Fucidin has minimal systemic absorption when used as directed, so interactions are unlikely. Do not layer other topical antibiotics, steroids, or antiseptics over the same area without guidance, as combinations can irritate skin, dilute effect, or mask infection. If you are already prescribed a topical corticosteroid for eczema, your clinician may recommend structured use (for example, applying the antibiotic first, allowing absorption, then steroid) for short durations only.
Systemic fusidic acid is a known interaction risk. It can increase blood levels of statins (simvastatin, atorvastatin, rosuvastatin), raising the chance of myopathy or rhabdomyolysis; the combination is generally contraindicated or requires temporary statin interruption with careful monitoring. Fusidic acid may also interact with warfarin (altering INR), certain HIV protease inhibitors, cyclosporine, and rifampicin (often co-prescribed but only with expert oversight). Always provide a full medication list—including over-the-counter products—to your clinician before starting fusidic acid in any form.
If you forget a topical or ophthalmic dose of Fucidin, apply or instill it as soon as you remember. If it is almost time for the next scheduled dose, skip the missed dose and resume your regular schedule. Do not double up to “catch up,” as this increases irritation without improving effectiveness. For systemic fusidic acid, follow your clinician’s instructions; if multiple doses are missed, contact the prescriber for advice.
Topical overdose is unlikely to cause systemic toxicity but may lead to pronounced local irritation, redness, or dermatitis; wash off excess with mild soap and water and allow the skin to rest. Accidental ingestion, especially by a child, may cause nausea, vomiting, or abdominal discomfort; seek medical advice or contact Poison Control (1-800-222-1222 in the U.S.). Overuse of any antibiotic can promote resistance; use Fucidin only as directed and for the prescribed duration.
Store Fucidin cream or ointment at room temperature, ideally 20–25°C (68–77°F), away from excess heat and moisture. Do not freeze. Keep the cap tightly closed and the tube out of reach of children and pets. Discard opened ophthalmic products according to label guidance, commonly 28 days after opening, to reduce contamination risk. Do not use past the expiration date or if the product’s color, smell, or consistency changes. If you travel, keep the tube in a clean, sealed pouch and avoid leaving it in a hot car.
In the United States, antibiotics typically require a prescription to support safe use and antimicrobial stewardship. Culpeper Regional Health System offers a legal, structured pathway to buy Fucidin without prescription through clinician-guided protocols. Rather than “no oversight,” the service uses a brief health questionnaire, targeted screening for red flags, and, when appropriate, same-day provider authorization under standing orders. This ensures the right patients get timely access, while those needing alternative care are redirected promptly.
Here is how it works: you submit your symptoms, history, photos of the affected area (if skin), and medication list through a secure portal; a licensed clinician or pharmacist reviews for suitability, interactions, and warning signs. If Fucidin is appropriate, a valid order is issued and fulfilled by a U.S.-based pharmacy with transparent pricing, discreet shipping, and aftercare instructions. If not, you receive guidance on next steps, including in-person evaluation. This compliant model balances convenience, safety, and responsible antibiotic use.
Fucidin is a brand name for fusidic acid, a topical antibiotic that stops bacteria from making proteins they need to grow. It is especially active against Staphylococcus aureus, a common cause of skin infections.
Fucidin is used for localized bacterial skin infections such as impetigo, infected eczema, folliculitis, and minor infected cuts or abrasions. It does not treat fungal infections, viral infections like cold sores, or noninfected rashes.
Clean and dry the affected skin, then apply a thin layer 3 to 4 times daily or as directed by your clinician. Wash hands before and after use, and avoid the eyes, mouth, and deep wounds.
Most courses last 5 to 7 days and should not exceed 10 days unless your clinician advises otherwise. If there is no improvement after 3 days, seek medical advice.
Topical fusidic acid has minimal absorption and is generally considered safe in pregnancy and breastfeeding. Avoid applying to the nipple area, or gently wash the area before nursing.
It can be used on facial skin if prescribed, but keep it out of the eyes. If it gets into the eyes, rinse thoroughly with water and seek advice if irritation persists.
It is not a first-line acne treatment and should only be used if a clinician suspects a secondary bacterial infection. For routine acne, use evidence-based acne therapies instead.
Mild stinging, burning, itching, or dryness can occur at the application site. Rarely, allergic rash or contact dermatitis may develop; stop use and seek help if severe irritation or swelling occurs.
Yes. To reduce resistance, use Fucidin only for clear bacterial infections, apply it for short prescribed courses, and avoid repeated or widespread use without medical guidance.
Apply it when you remember. If it is close to the next dose, skip the missed application and continue as scheduled. Do not double-apply.
Yes, but separate applications by at least 15 to 30 minutes to reduce dilution or irritation. Your clinician may prescribe a combined product like Fucidin H when inflammation is prominent.
A light, breathable dressing can protect weeping or exposed lesions if advised. Avoid tight occlusive dressings unless instructed, as they can increase irritation.
In many countries it requires a prescription; availability varies by region. Use only under professional advice to prevent misuse and resistance.
Keep it tightly capped at room temperature, away from heat and direct light, and out of children’s reach. Do not use after the expiry date.
If redness or pain worsens, the infection spreads, you develop fever, or there is no improvement within 72 hours, contact your healthcare provider.
Fusidic acid can be active against some MRSA strains, but resistance is common and local patterns vary. Your clinician will choose the most appropriate therapy based on guidelines and culture results when needed.
Nasal use is not routine with standard Fucidin skin formulations. Mupirocin nasal ointment is typically preferred for decolonization when indicated.
Only if your surgeon or clinician advises it. Many clean surgical wounds do not need topical antibiotics, and overuse can promote resistance.
Routine preventive use is not recommended; clean with mild soap and water and consider an antiseptic if needed. Reserve antibiotics like Fucidin for confirmed infection.
Fusidic acid is not known for photosensitivity, but irritated skin is more sensitive; use sun protection and avoid harsh sun on inflamed areas.
Both are effective topical antibiotics, but many guidelines favor mupirocin or retapamulin as first-line due to resistance patterns. Fucidin remains useful where local fusidic acid resistance is low.
Mupirocin nasal ointment is the standard for MRSA decolonization when indicated. Fucidin is generally not recommended for nasal decolonization.
Fucidin H combines fusidic acid with hydrocortisone to treat inflamed, infected eczema. Use it short term and avoid prolonged or large-area application to limit steroid side effects like skin thinning.
Cream suits moist or weeping lesions and hair-bearing areas, while ointment is better for dry, crusted, or fissured skin and offers more occlusion. Your clinician may choose based on lesion type and location.
Fucidin (fusidic acid) targets staph species well and is prescription-only in many regions. Neosporin (neomycin, polymyxin B, bacitracin) is often OTC but carries a higher risk of allergic contact dermatitis, especially from neomycin.
Bacitracin has narrower Gram-positive coverage and a higher rate of contact allergy. Fucidin generally offers stronger activity against Staphylococcus aureus but should still be used judiciously.
Gentamicin has better Gram-negative coverage; fusidic acid is stronger against staph. Choice depends on likely bacteria, site, and culture results when available.
Retapamulin is applied twice daily for 5 days and is effective for impetigo with a low resistance rate. Fucidin is an alternative where sensitivity is confirmed and resistance is low.
Ozenoxacin treats impetigo, including some MRSA, with twice-daily dosing for 5 days and low systemic absorption. Availability and cost may influence choice versus Fucidin.
Topical clindamycin is mainly used for acne (usually combined with benzoyl peroxide) and is not a first-line agent for impetigo. Fucidin is preferred for localized staph skin infections when indicated.
For very mild, localized impetigo, an antiseptic like hydrogen peroxide 1 percent may be tried first in some guidelines to curb antibiotic use. Fucidin is reserved for clearer bacterial infections or when antiseptics fail.
Topical Fucidin is suitable for small, localized lesions without systemic symptoms. Oral antibiotics are preferred for extensive disease, spreading cellulitis, systemic signs, or high-risk sites such as around the nose and lips.
Bactroban is a brand of mupirocin; compared with Fucidin, it is often first-line for impetigo and for MRSA nasal decolonization. Local resistance patterns and individual tolerability guide selection.
Antiseptics can be adequate for minor, superficial wounds without clear infection and help reduce antibiotic overuse. If signs of bacterial infection are present, a targeted topical antibiotic like Fucidin may be appropriate under guidance.
Lets get in touch if you have any questions.